Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries
BACKGROUND: Adverse effects from childhood leukemia treatment may persist or present years after cure from cancer. We provide a comprehensive evaluation of subsequent hospitalization in five-year survivors of childhood acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic mye...
Published in: | JNCI: Journal of the National Cancer Institute |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 https://doi.org/10.1093/jnci/djz016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748786/pdf/djz016.pdf |
id |
ftuniaarhuspubl:oai:pure.atira.dk:publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 |
---|---|
record_format |
openpolar |
spelling |
ftuniaarhuspubl:oai:pure.atira.dk:publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 2024-06-23T07:54:04+00:00 Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries Sørensen, Gitte Vrelits Winther, Jeanette Falck Licht, Sofie de Fine Andersen, Klaus Kaae Holmqvist, Anna Sällfors Madanat-Harjuoja, Laura M Tryggvadottir, Laufey Bautz, Andrea Lash, Timothy L Hasle, Henrik 2019-02-11 https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 https://doi.org/10.1093/jnci/djz016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748786/pdf/djz016.pdf eng eng https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 info:eu-repo/semantics/openAccess Sørensen , G V , Winther , J F , Licht , S D F , Andersen , K K , Holmqvist , A S , Madanat-Harjuoja , L M , Tryggvadottir , L , Bautz , A , Lash , T L & Hasle , H 2019 , ' Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries ' , Journal of the National Cancer Institute , vol. 111 , no. 9 , djz016 , pp. 943-951 . https://doi.org/10.1093/jnci/djz016 article 2019 ftuniaarhuspubl https://doi.org/10.1093/jnci/djz016 2024-06-04T14:24:06Z BACKGROUND: Adverse effects from childhood leukemia treatment may persist or present years after cure from cancer. We provide a comprehensive evaluation of subsequent hospitalization in five-year survivors of childhood acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML). METHODS: In the Adult Life after Childhood Cancer in Scandinavia Study, we identified 4003 five-year survivors diagnosed with childhood leukemia 1970-2008 in Denmark, Sweden, Iceland, and Finland. Survivors and 129 828 population comparisons were followed for first-time nonpsychiatric hospitalizations for 120 disease categories in the hospital registries. Standardized hospitalization rate ratios and absolute excess rates were calculated. All statistical tests were two-sided. RESULTS: Survivors of ALL (n = 3391), AML (n = 389), and CML (n = 92) had an increased overall hospitalization rate compared with population comparisons. The rate ratio for any hospitalization was 1.95 (95% confidence interval [CI] = 1.83 to 2.07) in ALL, 3.09 (95% CI = 2.53 to 3.65) in AML, and 4.51 (95% CI = 3.03 to 6.00) in CML survivors and remained increased even 20 years from leukemia diagnosis. Corresponding absolute excess rates per 1000 person-years were 28.48 (95% CI = 24.96 to 32.00), 62.75 (95% CI = 46.00 to 79.50), and 105.31 (95% CI = 60.90 to 149.72). CONCLUSION: Leukemia survivors have an increased rate of hospitalization for medical conditions. We provide novel insight into the relative and absolute rate of hospitalization for 120 disease categories in survivors of ALL, AML, and CML, which are likely to be informative for both survivors and healthcare providers. Article in Journal/Newspaper Iceland Aarhus University: Research JNCI: Journal of the National Cancer Institute 111 9 943 951 |
institution |
Open Polar |
collection |
Aarhus University: Research |
op_collection_id |
ftuniaarhuspubl |
language |
English |
description |
BACKGROUND: Adverse effects from childhood leukemia treatment may persist or present years after cure from cancer. We provide a comprehensive evaluation of subsequent hospitalization in five-year survivors of childhood acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML). METHODS: In the Adult Life after Childhood Cancer in Scandinavia Study, we identified 4003 five-year survivors diagnosed with childhood leukemia 1970-2008 in Denmark, Sweden, Iceland, and Finland. Survivors and 129 828 population comparisons were followed for first-time nonpsychiatric hospitalizations for 120 disease categories in the hospital registries. Standardized hospitalization rate ratios and absolute excess rates were calculated. All statistical tests were two-sided. RESULTS: Survivors of ALL (n = 3391), AML (n = 389), and CML (n = 92) had an increased overall hospitalization rate compared with population comparisons. The rate ratio for any hospitalization was 1.95 (95% confidence interval [CI] = 1.83 to 2.07) in ALL, 3.09 (95% CI = 2.53 to 3.65) in AML, and 4.51 (95% CI = 3.03 to 6.00) in CML survivors and remained increased even 20 years from leukemia diagnosis. Corresponding absolute excess rates per 1000 person-years were 28.48 (95% CI = 24.96 to 32.00), 62.75 (95% CI = 46.00 to 79.50), and 105.31 (95% CI = 60.90 to 149.72). CONCLUSION: Leukemia survivors have an increased rate of hospitalization for medical conditions. We provide novel insight into the relative and absolute rate of hospitalization for 120 disease categories in survivors of ALL, AML, and CML, which are likely to be informative for both survivors and healthcare providers. |
format |
Article in Journal/Newspaper |
author |
Sørensen, Gitte Vrelits Winther, Jeanette Falck Licht, Sofie de Fine Andersen, Klaus Kaae Holmqvist, Anna Sällfors Madanat-Harjuoja, Laura M Tryggvadottir, Laufey Bautz, Andrea Lash, Timothy L Hasle, Henrik |
spellingShingle |
Sørensen, Gitte Vrelits Winther, Jeanette Falck Licht, Sofie de Fine Andersen, Klaus Kaae Holmqvist, Anna Sällfors Madanat-Harjuoja, Laura M Tryggvadottir, Laufey Bautz, Andrea Lash, Timothy L Hasle, Henrik Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries |
author_facet |
Sørensen, Gitte Vrelits Winther, Jeanette Falck Licht, Sofie de Fine Andersen, Klaus Kaae Holmqvist, Anna Sällfors Madanat-Harjuoja, Laura M Tryggvadottir, Laufey Bautz, Andrea Lash, Timothy L Hasle, Henrik |
author_sort |
Sørensen, Gitte Vrelits |
title |
Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries |
title_short |
Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries |
title_full |
Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries |
title_fullStr |
Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries |
title_full_unstemmed |
Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries |
title_sort |
long-term risk of hospitalization among five-year survivors of childhood leukemia in the nordic countries |
publishDate |
2019 |
url |
https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 https://doi.org/10.1093/jnci/djz016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748786/pdf/djz016.pdf |
genre |
Iceland |
genre_facet |
Iceland |
op_source |
Sørensen , G V , Winther , J F , Licht , S D F , Andersen , K K , Holmqvist , A S , Madanat-Harjuoja , L M , Tryggvadottir , L , Bautz , A , Lash , T L & Hasle , H 2019 , ' Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries ' , Journal of the National Cancer Institute , vol. 111 , no. 9 , djz016 , pp. 943-951 . https://doi.org/10.1093/jnci/djz016 |
op_relation |
https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 |
op_rights |
info:eu-repo/semantics/openAccess |
op_doi |
https://doi.org/10.1093/jnci/djz016 |
container_title |
JNCI: Journal of the National Cancer Institute |
container_volume |
111 |
container_issue |
9 |
container_start_page |
943 |
op_container_end_page |
951 |
_version_ |
1802646020300996608 |